Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$304.11 - $351.99 $1.09 Million - $1.27 Million
-3,598 Reduced 55.64%
2,868 $991,000
Q4 2023

Feb 08, 2024

BUY
$269.37 - $365.04 $1.71 Million - $2.32 Million
6,344 Added 5200.0%
6,466 $2.09 Million
Q3 2023

Oct 27, 2023

BUY
$350.25 - $422.63 $42,730 - $51,560
122 New
122 $43,000
Q1 2023

May 09, 2023

SELL
$418.69 - $503.0 $837 - $1,006
-2 Reduced 0.05%
3,659 $1.75 Million
Q4 2022

Feb 10, 2023

BUY
$351.71 - $456.01 $1.29 Million - $1.67 Million
3,661 New
3,661 $1.54 Million
Q2 2022

Aug 08, 2022

SELL
$463.67 - $597.16 $721,006 - $928,583
-1,555 Reduced 45.36%
1,873 $927,000
Q1 2022

May 13, 2022

SELL
$524.57 - $735.42 $2.15 Million - $3.01 Million
-4,092 Reduced 54.41%
3,428 $1.93 Million
Q4 2021

Feb 11, 2022

BUY
$708.84 - $794.68 $720,181 - $807,394
1,016 Added 15.62%
7,520 $5.68 Million
Q3 2021

Nov 02, 2021

BUY
$657.71 - $825.77 $3.11 Million - $3.91 Million
4,734 Added 267.46%
6,504 $4.85 Million
Q2 2021

Aug 13, 2021

BUY
$576.64 - $649.04 $197,787 - $222,620
343 Added 24.04%
1,770 $1.14 Million
Q1 2021

May 12, 2021

SELL
$547.01 - $662.35 $547 - $662
-1 Reduced 0.07%
1,427 $815,000
Q4 2020

Feb 11, 2021

BUY
$510.68 - $643.45 $487,699 - $614,494
955 Added 201.9%
1,428 $832,000
Q3 2020

Nov 12, 2020

BUY
$454.43 - $535.6 $214,945 - $253,338
473 New
473 $244,000
Q4 2018

Feb 13, 2019

SELL
$220.1 - $309.0 $674,166 - $946,467
-3,063 Closed
0 $0
Q3 2018

Nov 06, 2018

SELL
$289.28 - $326.15 $11,281 - $12,719
-39 Reduced 1.26%
3,063 $959,000
Q2 2018

Aug 10, 2018

BUY
$244.1 - $303.88 $757,198 - $942,635
3,102 New
3,102 $895,000
Q1 2018

May 07, 2018

SELL
$233.97 - $274.11 $540,470 - $633,194
-2,310 Closed
0 $0
Q4 2017

Feb 06, 2018

BUY
$216.94 - $271.3 $127,343 - $159,253
587 Added 34.07%
2,310 $551,000
Q3 2017

Nov 08, 2017

BUY
$212.27 - $242.28 $365,741 - $417,448
1,723
1,723 $383,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.41B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Ing Groep Nv Portfolio

Follow Ing Groep Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

News

Stay updated on Ing Groep Nv with notifications on news.